Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email